List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #7,331 to #7,380.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Bisoprolol clinical studiesBisoprolol#Clinical Studies
  2. Bisoprolol contraindicationsBisoprolol#Contraindications
  3. Bisoprolol descriptionBisoprolol#Structure
  4. Bisoprolol detailed informationBisoprolol
  5. Bisoprolol dosage and administrationBisoprolol#Adult Indications and Dosage
  6. Bisoprolol drug interactionsBisoprolol#Drug Interactions
  7. Bisoprolol how supplied storage and handlingBisoprolol#How Supplied
  8. Bisoprolol indications and usageBisoprolol#Adult Indications and Dosage
  9. Bisoprolol labels and packagesBisoprolol#Package and Label Display Panel
  10. Bisoprolol nonclinical toxicologyBisoprolol#Nonclinical Toxicology
  11. Bisoprolol overdosageBisoprolol#Overdosage
  12. Bisoprolol patient counseling informationBisoprolol#Patient Counseling Information
  13. Bisoprolol use in specific populationsBisoprolol#Use in Specific Populations
  14. Bisoprolol warnings and precautionsBisoprolol#Warnings
  15. Bispecific antibodiesBispecific antibody
  16. BisphosphonatesBisphosphonate
  17. BisulfateSulfate
  18. Bite (medicine)Bite
  19. Bite WoundBite
  20. Bite WoundsBite
  21. Bite injuryBite
  22. Bite woundBite
  23. Bite woundsBite
  24. Bitemporal hemianopsiaBitemporal hemianopia
  25. BitesBite
  26. Bitolterol Oral InhalationBitolterol Oral Inhalation (patient information)
  27. Bitolterol mesylateBitolterol
  28. Bitot's spotBitot's spots
  29. Bitter (taste)Taste#bitterness
  30. Bitter tasteTaste#Bitterness
  31. Bivalirudin adverse reactionsBivalirudin#Adverse Reactions
  32. Bivalirudin clinical pharmacologyBivalirudin#Pharmacology
  33. Bivalirudin clinical studiesBivalirudin#Clinical Studies
  34. Bivalirudin contraindicationsBivalirudin#Contraindications
  35. Bivalirudin descriptionBivalirudin#Structure
  36. Bivalirudin dosage and administrationBivalirudin#Adult Indications and Dosage
  37. Bivalirudin dosage forms and strengthsBivalirudin#How Supplied
  38. Bivalirudin drug interactionsBivalirudin#Drug Interactions
  39. Bivalirudin during primary PCI reduces major bleeding and adverse events at 30 days in the HORIZONS-AMI trialSpecial:Badtitle/NS100:Bivalirudin during primary PCI reduces major bleeding and adverse events at 30 days in the HORIZONS-AMI trial
  40. Bivalirudin how suppliedBivalirudin#How Supplied
  41. Bivalirudin how supplied storage and handlingBivalirudin#How Supplied
  42. Bivalirudin indicationsBivalirudin#Adult Indications and Dosage
  43. Bivalirudin indications and usageBivalirudin#Adult Indications and Dosage
  44. Bivalirudin instructions for administrationBivalirudin#Patient Counseling Information
  45. Bivalirudin is no better than heparin in patients pretreated with clopidogrel undergoing PCI: Results from the ISAR-REACT-3 trialSpecial:Badtitle/NS100:Bivalirudin is no better than heparin in patients pretreated with clopidogrel undergoing PCI: Results from the ISAR-REACT-3 trial
  46. Bivalirudin labels and packagesBivalirudin#Package and Label Display Panel
  47. Bivalirudin mechanism of actionBivalirudin#Pharmacology
  48. Bivalirudin nonclinical toxicologyBivalirudin#Nonclinical Toxicology
  49. Bivalirudin overdosageBivalirudin#Overdosage
  50. Bivalirudin patient counseling informationBivalirudin#Patient Counseling Information

View ( | ) (20 | 50 | 100 | 250 | 500)